nGL 12.5 (Movantik 12.5 mg)

Generic Name: naloxegol

Pill imprint nGL 12.5 has been identified as Movantik 12.5 mg.

Movantik is used in the treatment of constipation, drug induced; constipation, chronic and belongs to the drug class peripheral opioid receptor antagonists. Risk cannot be ruled out during pregnancy. Movantik 12.5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Movantik

Generic Name:

naloxegol

Imprint:

nGL 12.5

Strength:

12.5 mg

Color:

Purple

Shape:

Elliptical / Oval

Availability:

Prescription only

Drug Class:

Peripheral opioid receptor antagonists

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

AstraZeneca Pharmaceuticals LP

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.